Evidence map›Paper›PMID 36330283›Full record

ArticleAIMS public health2022

Assessment of cardiovascular risk factors among HIV-infected patients aged 50 years and older in Cameroon.

Henri Olivier Tatsilong Pambou, Amandine Gagneux-Brunon, Bertrand Tatsinkou Fossi, Frederic Roche, Jessica Guyot, Elisabeth Botelho-Nevers, Caroline Dupre, Bienvenu Bongue, Celine Nguefeu Nkenfou

Abstract read
In one paragraph

Article in AIMS public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Henri Olivier Tatsilong PambouUniversity of Buea, Faculty of Sciences, Buea, Cameroon.
Amandine Gagneux-BrunonCIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Inserm, U1111, CNRS, UMR530, F42023 Saint-Etienne, France.
Bertrand Tatsinkou FossiUniversity of Buea, Faculty of Sciences, Buea, Cameroon.
Frederic RocheINSERM, UMR 1059, SAINBIOSE, University Jean Monnet, Saint-Etienne, France.
Jessica GuyotINSERM, UMR 1059, SAINBIOSE, University Jean Monnet, Saint-Etienne, France.
Elisabeth Botelho-NeversCIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Inserm, U1111, CNRS, UMR530, F42023 Saint-Etienne, France.
Caroline DupreINSERM, UMR 1059, SAINBIOSE, University Jean Monnet, Saint-Etienne, France.
Bienvenu BongueINSERM, UMR 1059, SAINBIOSE, University Jean Monnet, Saint-Etienne, France.
Celine Nguefeu NkenfouChantal Biya International Reference Centre, System Biology Laboratory, Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increasing the longevity of people living with HIV (PLHIV) around the world has been accompanied by an increase in the prevalence of cardiovascular disease (CVD) risk factors and morbidity. The impact of these trends on the epidemiology of CVD among PLHIV is less clear. The aim of this study was to assess the risk factors for CVD, and to estimate these risks at 10 years in PLHIV aged 50 and above. Methods: This was a descriptive and analytical study carried out at Mvog Ada District Hospital in Yaounde, Cameroon from January 2020 to January 2021. Descriptive bivariate analyses were used to present the data. The data are presented as frequencies and percentages for categorical variables, and in terms of means and standard deviations for continuous variables where appropriate. The 10-year CVD risk score was calculated using two tools: the validated Framingham risk score (FRS) (low < 10%, moderate 10-20% and high ≥ 20%) and SCORE score (SSC) (low < 3%, moderate 3-4% and high ≥ 5%). Multiple logistic regression models were constructed to examine the respective relationships between the binary dependent variable high CVD risk (FRS ≥ 20%) and the population group, alcohol consumption (more than 10 glasses of beer per week, or more than 35.7 cl/day) and hypertriglyceridemia (independent variables). A p-value less than or equal to 0.05 was considered statistically significant. Results: A total of 112 people aged 50 and above were enrolled in the study out of 180 people registered at the HIV care unit, that is a participation rate of 62.22%. The average age of the participants was 57.3 ± 6.4 years, and the female/male ratio was 1.6. The majority of participants (53.57%) had normal glycaemia levels (<1.10 g/L), 4.46% were diabetic and 46.40% had high blood pressure. The adherence rate for ARV treatment was 98.20%; most participants (77.20%) were alcohol consumers, and 28.10% of participants had hypertriglyceridemia. The estimates of overall cardiovascular risk in 10 years presented 50.90% of participants with low risk, 33% with moderate risk and 16.10% with high risk. Conclusions: Our study indicated an overall risk of cardiovascular events in 10 years is 16.10%, with the main conditional risk factor being hypertriglyceridemia and alcohol consumption, which appeared to triple the risk of CVD among PLHIV.

Indexed as

HDL cholesterolPLHIVrisk of cardiovascular events

Identifiers

PMID36330283
PMCPMC9581741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.